Orchid Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Orchid Pharma Ltd. on BSE

Load latest

Orchid Pharma Ltd.

26 May 2025, 04:06PM

703.45

0.01%

Result

Orchid Pharma Ltd - 524372 - Annual Audited Financial Results For The Quarter And F.Y. Ended …

BSE India

Annual Audited Financial Results for the quarter and F.Y.2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	241.38	225.83	230.46	6.9%	4.7%
Operating Profit Qtr	27.98	26.36	28.92	6.1%	-3.3%
Net Profit Qtr	22.29	20.78	32.96	7.3%	-32.4%
Earning Per Share Adjusted latest Qtr	4.40	4.10	6.50	7.3%	-32.3%

* Consolidated data

Detailed Results

Orchid Pharma Ltd.

26 May 2025, 03:54PM

703.45

0.01%

Board Meeting

Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting For Considering …

BSE India

Outcome of Board Meeting for considering and approving Annual Audited Financial Results for the quarter and F.Y. ended on March 31, 2025

pdf

Orchid Pharma Ltd.

25 May 2025, 12:32AM

703.45

0.01%

AGM

Orchid Pharma Ltd - 524372 - Notice Of Meeting Of Equity Shareholders And Unsecured Creditors Of …

BSE India

Notice of Meeting of Equity Shareholders and Unsecured Creditors of Orchid Pharma Ltd convened pursuant to the order passed by Hon''ble National Company Law Tribunal for considering and approving the Scheme of Amalgamation of Dhanuka Laboratories Ltd with Orchid Pharma Ltd and their respective shareholders and creditors.

pdf

Orchid Pharma Ltd.

20 May 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of schedule of Analysts/ Investors Earning Call for the Quarter-IV and Financial Year ended on March 31, 2025

pdf

Orchid Pharma Ltd.

20 May 2025

703.45

0.01%

Board Meeting

Orchid Pharma Ltd - 524372 - Board Meeting Intimation for The Board Meeting Scheduled To Be …

BSE India

Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidate) of the company for the Quarter-IV and Financial Year ended on March 31, 2025

pdf

Orchid Pharma Ltd.

15 May 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Monitoring Agency report for the Quarter-IV of Financial Year 2024-25, ended on March 31, 2025 of Orchid Pharma Limited

pdf

Orchid Pharma Ltd.

13 May 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Intimation Related To The Scheme Of Amalgamation Of Dhanuka Laboratories …

BSE India

Intimation related to the Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors.

pdf

Orchid Pharma Ltd.

10 May 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30 Read With Schedule III Of SEBI …

BSE India

Intimation under Regulation 30 read with Schedule III of SEBI Listing Regulations, 2015

pdf

Orchid Pharma Ltd.

03 May 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Intimation On Scheme Of Amalgamation Of Dhanuka Laboratories Limited ("Amalgamating …

BSE India

Intimation on Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Company"/"Amalgamated Company") and their respective shareholders and creditors under Regulation 30 SEBI Listing Regulations, 2015.

pdf

Orchid Pharma Ltd.

11 Apr 2025

703.45

0.01%

Company Update

Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for Quarter IV of F.Y. 2024-25, ended on March 31, 2025

pdf

Is Orchid Pharma Ltd. worth buying?

209 Votes:

Buy 73.68%

Sell 17.22%

Hold 9.09%